Rare diseases
Investigational molecules
Locations
Passeig Maritim De La Barceloneta 25-29, 08003 Barcelona, Spain
Hospital Del Mar in Barcelona, Spain specialises in clinical trials of conditions such as Non-small cell lung cancer, Breast cancer, Breast cancer metastatic, Prostate cancer, and other specialisations. This site conducts important research.
The Hospital Del Mar conducts extensive research in cancer across multiple organ systems, aiming to test new targeted agents and combination regimens that improve survival and quality of life.
The program emphasizes precision medicine, biomarker‑driven enrollment, and supportive care strategies for patients with high‑risk solid tumours.
A broad portfolio of trials addresses bacterial, viral and fungal infections, evaluating novel antimicrobials, vaccine approaches and diagnostic improvements.
Research integrates antimicrobial stewardship principles and rapid diagnostic techniques to reduce morbidity and resistance.
Clinical investigations target heart disease, hypertension and lipid disorders, focusing on therapies that lower event rates and manage chronic conditions.
The site leverages advanced imaging and biomarker profiling to personalize cardiovascular risk reduction.
Trials in the neurological field explore disease‑modifying treatments and symptom control for progressive disorders such as ALS, multiple sclerosis and Alzheimer’s disease.
Patient‑reported outcomes and functional assessments are central to evaluating therapeutic impact.
Research at Hospital Del Mar includes kidney transplantation and a range of autoimmune conditions, seeking to improve graft tolerance and control immune dysregulation.
The program combines novel immunosuppressive regimens with biomarker monitoring to enhance long‑term graft survival.
Clinical trials currently enrolling participants at this site.
Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
SpainSpainA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
SpainSafety Study of NB-4746 with Riluzole and Placebo in Adults with Amyotrophic Lateral Sclerosis (ALS)
SpainLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
SpainA study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis
SpainA study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
SpainA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
SpainA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
SpainStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
SpainA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
SpainStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
